exhibited obviously improved IC50 values ranging from 0.7 to 1.2 μM against a panel of tested cancer cells, but also showed very weak cytotoxicity on normal cells. Preliminary mechanism studies indicated that compound 24 could induce apoptosis in MDA-MB-231 cells and was worth developing into a novel natural product-like anticancer lead by proper structure modification.
已经建立了一种简洁有效的合成方法,以中到高收率容易地获得一系列新颖的C-14
1,2,3-三唑系绳的
脱氢松香酸衍
生物。体外抗增殖活性评估表明,大多数杂种在低微摩尔至亚微摩尔IC 50值的多种癌
细胞系中均表现出有效的抑制活性。进一步的研究表明,一些这些类似物如20,21,和24也针对在低浓度以剂量依赖性方式耐
阿霉素MCF-7克隆有效。值得注意的是,最有效的化合物24具有3-(叔-丁氧基羰基
氨基)苯基取代的三唑部分不仅对一组经过测试的癌细胞表现出明显改善的IC 50值,范围为0.7至1.2μM,而且对正常细胞的毒性也很弱。初步的机理研究表明,化合物24可以诱导
MDA-MB-231细胞凋亡,通过适当的结构修饰,值得发展为新型的
天然产物样抗癌药。